パピローマウイルスワクチン
WordNet
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
PrepTutorEJDIC
- 牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination.
- Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, Robertson M, Shearman CA, Castle PE; For The New Mexico HPV Pap Registry Steering Committee.SourceDepartment of Pathology and Department of Obstetrics and Gynecology, University of New Mexico Health Sciences Center, House of Prevention Epidemiology (HOPE), Albuquerque, NM. cwheeler@salud.unm.edu.
- International journal of cancer. Journal international du cancer.Int J Cancer.2013 Jan 1;132(1):198-207. doi: 10.1002/ijc.27608. Epub 2012 Jun 20.
- Currently, two prophylactic human papillomavirus (HPV) vaccines targeting HPV 16 and 18 have been shown to be highly efficacious for preventing precursor lesions although the effectiveness of these vaccines in real-world clinical settings must still be determined. Toward this end, an ongoing statewi
- PMID 22532127
- Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination.
- Palmroth J, Merikukka M, Paavonen J, Apter D, Eriksson T, Natunen K, Dubin G, Lehtinen M.SourceUniversity of Kuopio Hospital, Kuopio, Finland.
- International journal of cancer. Journal international du cancer.Int J Cancer.2012 Dec 15;131(12):2832-8. doi: 10.1002/ijc.27586. Epub 2012 Apr 30.
- Control of human papillomavirus (HPV)-related cancers by inclusion of HPV vaccination into national vaccination programmes is likely. One open question is replacement of the vaccine types with other high-risk (hr) HPV types in the vaccination era. We studied occurrence of HPV types in adolescent fem
- PMID 22492244
Japanese Journal
- Enhancement of DNA Vaccine Potency Against Hamster Oral Papillomavirus-Associated Oral Cancer by Electroporation in vivo
- Safety and Immunogenicity of a 9-Valent Human Papillomavirus Vaccine Administered to 9- to 15-Year-Old Japanese Girls
Related Links
- FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and ...
- Why does my child need HPV vaccine? HPV vaccine is important because it protects against cancers caused by human papillomavirus (HPV) infection. HPV is a very common virus; nearly 80 million people—about one in four—are ...
★リンクテーブル★
[★]
- 英
- papillomavirus vaccine
- 関
- ヒトパピローマウイルスワクチン
[★]
ヒトパピローマウイルスワクチン
[★]
- 英
- papillomavirus
- 同
- 乳頭腫ウイルス
- 関
- ヒトパピローマウイルス HPV human papillomavirus